Praxis Precision Medicines (PRAX) Capital Expenditures (2020 - 2026)
Praxis Precision Medicines (PRAX) posted quarterly Capital Expenditures of -$8000.0 for Q3 2025, down 112.5% quarter-over-quarter from $64000.0 in Q1 2025.
Praxis Precision Medicines (PRAX) Capital Expenditures (2020 - 2026) Analysis & Trends
Praxis Precision Medicines' Capital Expenditures history runs 5 years deep, the most recent figure standing at -$8000.0 for Q3 2025.
- In Q3 2025, Capital Expenditures changed N/A year-over-year to -$8000.0; the TTM figure through Mar 2026 stood at -$8000.0 (down 112.5% YoY), while the FY2025 annual figure was $56000.0, changed N/A from the prior year.
- Capital Expenditures for Q3 2025 stood at -$8000.0, down from $64000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $444000.0 in Q4 2022, with the low at -$399000.0 in Q3 2022.
- The 4-year median for Capital Expenditures is $64000.0 (2025), against an average of $74272.7.
- Peak annual rise in Capital Expenditures reached 7125.0% in 2022, while the deepest fall reached 1309.09% in 2022.
- Praxis Precision Medicines' Capital Expenditures stood at $151000.0 in 2021, then surged by 194.04% to $444000.0 in 2022, then sank by 88.74% to $50000.0 in 2023, then slumped by 116.0% to -$8000.0 in 2025.
- Business Quant data shows PRAX's Capital Expenditures at -$8000.0 in Q3 2025, $64000.0 in Q1 2025, and $50000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Praxis Precision Medicines | 10.24 Bn | 9.48 Bn | - | 711,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 711,000.00 |
| Jun 30, 2026 | 711,000.00 |
| Mar 31, 2026 | 62,000.00 |
| Mar 31, 2026 | 62,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Mar 31, 2025 | 64,000.00 |
| Mar 31, 2025 | 64,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Dec 31, 2022 | 444,000.00 |
| Dec 31, 2022 | 444,000.00 |
| Sep 30, 2022 | -399,000.00 |
| Sep 30, 2022 | -399,000.00 |
| Jun 30, 2022 | 110,000.00 |
| Jun 30, 2022 | 110,000.00 |
| Mar 31, 2022 | 289,000.00 |
| Mar 31, 2022 | 289,000.00 |
| Dec 31, 2021 | 151,000.00 |
| Dec 31, 2021 | 151,000.00 |